Reported results
- Total revenues for the three months ended September 30, 2026 were $115,000, compared to $137,000 for the same period in 2025.
- Gross profit was $71,000 for the three months ended September 30, 2026, compared to $125,000 for the same period in 2025.
- General and administrative expenses were $3.3 million for the three months ended September 30, 2026, compared to $3.6 million for the same period in 2025.
- Research and development expenses were $4.0 million for the three months ended September 30, 2026, compared to $3.9 million for the same period in 2025.
- Other income was $1.1 million for the three months ended September 30, 2026, compared to $0.1 million for the same period in 2025.
Guidance
- The Company currently anticipates its existing cash and cash equivalents will enable it to fund its operating expenses and capital expenditure requirements into the first quarter of 2027.
Notes
Effective August 26, 2026, the Company implemented a 1-for-10 reverse split of the shares of its Class A common stock and Class B common stock.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.
